A Review of Phase II Trial Designs for Initial Marker Validation

A review of phase II trial designs for initial marker validation.

By Sumithra J. Mandrekar, Ming-Wen An, Daniel J. Sargent

Contemp Clin Trials. 2013 May 8. pii: S1551-7144(13)00068-2. doi: 10.1016/j.cct.2013.05.001. [Epub ahead of print]


This program is open to the research community.

Date & Time(s)


Memorial Sloan Kettering Cancer Center
307 East 63rd Street
3rd Floor Conference Room
New York, NY 10065


Department of Epidemiology and Biostatistics